TLN-372 in Advanced KRAS Mutant Solid Tumors
TLN-372 in Advanced KRAS Mutant Solid Tumors
Recruiting · NCT07204340 · Registry updated 2026-07-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TLN-372 in Advanced KRAS Mutant Solid Tumors | KRAS Mutant Solid Tumors | Recruiting | Phase 1 | 2026-07-28 | NCT07204340 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Treeline Biosciences, Inc. | 4 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana-Farber Cancer Institute | Boston | United States | 1 |
| Hospital Universitary Vall d'Hebron | Barcelona | Spain | 1 |
| Linear Clinical Research | Perth | Australia | 12 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1 |
| Peter MacCallum Cancer Centre | Melbourne | Australia | 10 |
| Princess Margaret Cancer Centre | Toronto | Canada | 9 |
| Sarah Cannon Research Institute | Nashville | United States | 119 |
| START Madrid_Hospital Universitario HM Sanchinarro_CIOCC | Madrid | Spain | 2 |
| START Midwest | Grand Rapids | United States | 79 |
| University of Alabama at Birmingham | Birmingham | United States | 247 |
| Washington University Medical Campus | St Louis | United States | 1 |